America February 5, 2026
Eikon’s Upsized $381M IPO Ignites Nasdaq Debut
Oncology-focused biopharmaceutical firm Eikon Therapeutics stepped onto the public stage Thursday, as Eikon’s Upsized $381M IPO powered its Nasdaq debut…
America February 5, 2026
Oncology-focused biopharmaceutical firm Eikon Therapeutics stepped onto the public stage Thursday, as Eikon’s Upsized $381M IPO powered its Nasdaq debut…
By Rachel Moore
America January 6, 2026
Like a fintech heavyweight stepping onto a global stage, PicS has formally filed for a U.S. initial public offering, signaling…
By Rihem Akkouche
America December 2, 2025
Wealthfront, the Palo Alto-based robo-adviser known for its sleek automation and hands-off investment tools, officially launched plans Tuesday for an…
By Rihem Akkouche
America December 1, 2025
Construction services heavyweight Cardinal Infrastructure Group Inc. surged into the public markets Monday, unveiling a $242 million initial public offering…
By Rihem Akkouche
America July 21, 2025
In a daring pivot from its thwarted $20 billion union with Adobe, design-software phenom Figma has fired the starting gun…
By Rihem Akkouche
America February 24, 2025
Anne Wojcicki, CEO of 23andMe, has partnered with private equity powerhouse New Mountain Capital to take the pioneering genetic testing…
By Rihem Akkouche
America February 13, 2025
Aardvark Therapeutics Inc. made its public market debut Thursday, securing $94 million in its initial public offering (IPO). The obesity-focused…
By Rihem Akkouche
America February 12, 2025
Crypto trading giant eToro has officially set its sights on Wall Street, confirming on Wednesday that it has confidentially filed…
By Rihem Akkouche
America February 10, 2025
Biotechnology company Omega Therapeutics hit Chapter 11 bankruptcy in Delaware on Monday, listing more than $140 million in debt on…
By Rihem Akkouche